In 2023, KingMed Diagnostics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, KingMed Diagnostics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore KingMed Diagnostics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
In 2023, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics amounted to 34,374.54 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics decreased by 6.51%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2023, the total Scope 1 emissions of KingMed Diagnostics were 5,235.95 metric tons of CO₂ equivalent (tCO₂e). a
Since 2021, KingMed Diagnostics's Scope 1 emissions have decreased by 41.93%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2022), KingMed Diagnostics's Scope 1 emissions decreased by 30.49%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2023, KingMed Diagnostics reported Scope 2 greenhouse gas (GHG) emissions of 29,138.59 tCO₂e using the location-based method. a
Since 2021, KingMed Diagnostics's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 21.84%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2022), KingMed Diagnostics's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that KingMed Diagnostics 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, KingMed Diagnostics reported its Scope 2 emissions using the location-based method. a